Related Experiment Video

Updated: Mar 16, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.7K

Processed data for CHMS 2007-2009: Bisphenol A, phthalates and lead and learning and behavioral problems in Canadian

Tye E Arbuckle1, Karelyn Davis1, Khrista Boylan2

  • 1Population Studies Division, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada.

Data in Brief
|August 9, 2016
PubMed

Insights

Urinary BPA and phthalate metabolites may be associated with child behavioral and learning problems. This study analyzed Canadian Health Measures Survey data to explore these links in children aged 6-19.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Toxicology

Background:

  • Exposure to endocrine-disrupting chemicals (EDCs) like BPA and phthalates is widespread.
  • Childhood learning and behavioral issues, including attention deficit hyperactivity disorder (ADHD), are significant public health concerns.

Purpose of the Study:

  • To investigate the association between urinary BPA and phthalate metabolite concentrations and child learning and behavioral problems.
  • To consider covariates such as gender, blood lead, and environmental tobacco smoke (ETS) in the analysis.

Main Methods:

  • Analysis of cross-sectional data from Cycle 1 of the Canadian Health Measures Survey (CHMS).
  • Utilized the Strengths and Difficulties Questionnaire (SDQ) for emotional symptoms, hyperactivity/inattention, and total difficulties.
  • Examined outcomes including learning disability, ADD/ADHD, and psychotropic medication use.

Main Results:

  • Weighted logistic regression models were used to estimate associations.
  • Odds ratios were calculated for urinary BPA and phthalate metabolites in relation to ADHD, learning disability, and behavioral outcomes.
  • Specific gravity and blood lead levels were included as covariates.

Conclusions:

  • The study provides processed data on potential links between EDC exposure and child neurodevelopmental outcomes.
  • Findings contribute to understanding environmental influences on child behavior and learning.
  • Further research is warranted to confirm these associations and explore underlying mechanisms.

Keywords:
BehaviorBisphenol AChildrenLeadPhthalates

More Related Videos

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

6.5K
Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production06:46

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production

Published on: June 2, 2023

2.3K

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
100